1Jankovic J,Leder S,Warner D. Cervical dystonia:clinical findings and associated movement disorders[J].Neurology,1991.1088-1091.
2Nutt JG,Muenter MD,Aronson A. Epidemiology of focal and generalized dystonia in Rochester,Minnesota[J].Movement Disorders,1988.188-194.
3Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries[J].Journal of Neurology,2000.787-792.
4Duffey PO,Butler AG,Hawthorne MR. The epidemiology of the primary dystonias in the north of England[J].Advances in Neurology,1998.121-125.
5Velickovic M,Benabou R,Brin MF. Cervical dystonia pathophysiology and treatment options[J].Drugs,2001.1921-1943.
6Jahanshahi M,Marion MH,Marsden CD. Natural history of adult-onset idiopathic torticollis[J].Archives of Neurology,1990.548-552.
7Brashear A. Botulinum toxin type A in the treatment of patients with cervical dystonia[J].Biologics,2009.1-7.
8Jahanshahi M. Factors that ameliorate or aggravate spasmodic torticollis[J].Journal of Neurology Neurosurgery & Psychiatry,2000.227-229.
9Poisson A,Krack P,Thobois S. History of the ‘geste antagoniste' sign in cervical dystonia[J].Journal of Neurology,2012.
10Ochudlo S,Drzyzga K,Drzyzga LR. Various patterns of gestes antagonistes in cervical dystonia[J].Parkinsonism and Related Disorders,2007.417-420.